Publication:
Successful treatment of central nervous system involvement in posttransplant EBV-related lymphoproliferative disease with intrathecal rituximab therapy

Simple item page
dc.contributor.authorAslan, Fatma
dc.contributor.authorGüler, Salih
dc.contributor.authorEvim, Melike Sezgin
dc.contributor.authorAslıer, Mustafa
dc.contributor.authorYazıcı, Zeynep
dc.contributor.authorNazlıoğlu, Hülya Öztürk
dc.contributor.authorGüneş, Adalet Meral
dc.contributor.buuauthorASLAN, FATMA
dc.contributor.buuauthorGÜLER, SALİH
dc.contributor.buuauthorSEZGİN EVİM, MELİKE
dc.contributor.buuauthorASLIER, MUSTAFA
dc.contributor.buuauthorYAZICI, ZEYNEP
dc.contributor.buuauthorÖZTÜRK NAZLIOĞLU, HÜLYA
dc.contributor.buuauthorMERAL GÜNEŞ, ADALET
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi/Patoloji Anabilim Dalı.
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi/Pediatrik Radyoloji Anabilim Dalı.
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi/Kulak Burun Boğaz-Baş Boyun Cerrahisi Anabilim Dalı.
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi/Pediatrik Hematoloji Anabilim Dalı.
dc.contributor.orcid0000-0003-1577-8109
dc.contributor.orcid0000-0002-6180-901X
dc.contributor.researcheridGBG-1533-2022
dc.contributor.researcheridAAA-2856-2021
dc.contributor.researcheridIRI-7023-2023
dc.contributor.researcheridCCA-0193-2022
dc.contributor.researcheridAAI-2303-2021
dc.contributor.researcheridJIO-9152-2023
dc.contributor.researcheridJGX-6145-2023
dc.date.accessioned2024-11-12T06:54:38Z
dc.date.available2024-11-12T06:54:38Z
dc.date.issued2023-07-01
dc.description.abstractThe posttransplant lymphoproliferative disease is a severe cause of morbidity and mortality following allogeneic hematopoietic stem cell transplantation. Central Nervous System involvement in EBV-related PTLD is rare, and there is no standard treatment recommendation. We present our patient and discuss other previously reported cases of EBV-associated PTLD with CNS involvement.
dc.identifier.doi10.1097/MPH.0000000000002592
dc.identifier.endpageE630
dc.identifier.issn1077-4114
dc.identifier.issue5
dc.identifier.startpageE628
dc.identifier.urihttps://doi.org/10.1097/MPH.0000000000002592
dc.identifier.urihttps://journals.lww.com/jpho-online/fulltext/2023/07000/successful_treatment_of_central_nervous_system.26.aspx
dc.identifier.urihttps://hdl.handle.net/11452/47744
dc.identifier.volume45
dc.identifier.wos001017782300026
dc.indexed.wosWOS.SCI
dc.language.isoen
dc.publisherLippincott Williams & Wilkins
dc.relation.journalJournal of Pediatric Hematology Oncology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectStem-cell transplantation
dc.subjectCns
dc.subjectCns involvement
dc.subjectPtld
dc.subjectHsct
dc.subjectIntrathecal rituximab
dc.subjectOncology
dc.subjectHematology
dc.subjectPediatrics
dc.titleSuccessful treatment of central nervous system involvement in posttransplant EBV-related lymphoproliferative disease with intrathecal rituximab therapy
dc.typeArticle
dspace.entity.typePublication
relation.isAuthorOfPublicatione9b94b4c-a34e-4329-b495-78f23c76964e
relation.isAuthorOfPublication8ef9e002-892e-459a-80e7-cf08b69c48bb
relation.isAuthorOfPublicatione5dd9c52-ff4f-4fd0-9e37-2a7972f2b05f
relation.isAuthorOfPublicationb5345de0-476e-4283-ae7e-c2d12efbe71b
relation.isAuthorOfPublication523d917f-26be-4117-90bc-22d8bb2ec1a9
relation.isAuthorOfPublication9a6431a9-5a6a-4301-aff1-40eca42a12a0
relation.isAuthorOfPublication500825a8-5e0f-481f-a84f-d7fb8759c049
relation.isAuthorOfPublication.latestForDiscoverye9b94b4c-a34e-4329-b495-78f23c76964e

Files

Collections

Yeni Yayınlar